Showing results (21-30 of 55) with videos related to
Sort By:
Pageof 6
The New England Journal of Medicine|January 22, 2010
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosisGavin Giovannoni, Giancarlo Comi, Stuart Cook, et al.Sexually Transmitted Infections|December 22, 2016
Antiseptic mouthwash against pharyngeal <i>Neisseria gonorrhoeae</i>: a randomised controlled trial and an in vitro studyEric Pf Chow, Benjamin P Howden, Sandra Walker, et al.Stem Cell Research & Therapy|November 17, 2018
The prostaglandin H2 analog U-46619 improves the differentiation efficiency of human induced pluripotent stem cells into endothelial cells by activating both p38MAPK and ERK1/2 signaling pathwaysLiping Su, Xiaocen Kong, Szeyun Lim, et al.Clinical Drug Investigation|October 25, 2011
Reduction in healthcare and societal resource utilization associated with cladribine tablets in patients with relapsing-remitting multiple sclerosis: analysis of economic data from the CLARITY StudyShehzad Ali, Noman Paracha, Stuart Cook, et al.IEEE Transactions on Medical Imaging|November 8, 2018
Learning-Based Quality Control for Cardiac MR ImagesGiacomo Tarroni, Ozan Oktay, Wenjia Bai, et al.Sexually Transmitted Infections|December 2, 2015
Detection of Neisseria gonorrhoeae in the pharynx and saliva: implications for gonorrhoea transmissionEric P F Chow, David Lee, Sepehr N Tabrizi, et al.Nature Genetics|April 30, 2008
Distribution and functional impact of DNA copy number variation in the ratVictor Guryev, Kathrin Saar, Tatjana Adamovic, et al.European Heart Journal. Cardiovascular Imaging|April 8, 2020
The remodelling index risk stratifies patients with hypertensive left ventricular hypertrophyThu-Thao Le, Vanessa Lim, Rositaa Ibrahim, et al.Journal of Neurology|March 19, 2013
Efficacy and safety of interferon beta-1b sc in older RRMS patients--a posthoc analysis of the BEYOND studyChristian Lampl, Stefan Nagl, Barry Arnason, et al.Journal of Neurology|May 15, 2016
Incidence and course of depression in multiple sclerosis in the multinational BEYOND trialSven Schippling, Paul O'Connor, Volker Knappertz, et al.Pageof 6